08Dec

LGD-3033: Dosage, Usage and Benefits

What is LGd-3033 LGD 3303 is a type of SARM (Selective Androgen Receptor Modulators), which work similarly to steroids, medically known as anabolic-androgenic steroids. Anabolic refers to building muscle form using protein and nutrients. Although it is not the most well-known and perhaps not the most popular, it is thought that throughout more widely spread information the demand will only rise. SARMs were first invented in the late 1990’s as performance enhancing agents. Medical History It is always important to research information about the product you are buying before purchase, and read the ingredients carefully to make sure that it is real SARMs from a legitimate source. LGD 3303 is not the most common one to come by but when purchased correctly it has been tested as safe for human consumption. SARMs in general are a relatively new form of drug, LGD 3303 being even more recent. At the same…
08Dec

Ostarine (Mk2866): Dosage, Usage and Benefits

What is Ostarine? Ostarine is an oral selective androgen receptor modulator (SARM), also known as Enobosarm or MK-2866 in short. The SARM was originally under development by Merck & Company. In 1997, GTx Incorporated was formed, and soon afterward, they acquired and licensed the rights to MK-2866. Although GTx Inc. owns the rights of the drug, the compound was developed by several scientists, including James T. Dalton and Duane D. Miller of Ohio State University and the University of Tennessee, respectively. Since its development, Ostarine has gone through numerous trials. By 2013, GTx Inc. had already spent approximately $35 million on Ostarine. The drug had gone through two Phase II trials, one in 2007 and the other in 2011. In the 2011 double-blind placebo trial, Enobosarm was administered in postmenopausal women and elderly men. One of the goals of the trial was to investigate the effects of Enobosarm on cachexia…
08Dec

RAD-140: Dosage & Benefits

What is Rad-140? RAD140, also known as Testolone, is a very strong SARM (Selective Androgen Receptor Modulator). It is an investigational SARM, which means that it has not been tested very widely. Its benefits and side effects are not conclusive. It has not been approved by the FDA as of yet and is still under research. This drug is beneficial for bulking up quickly and preventing muscle wasting. It is also rumored to be a potential cure for breast cancer as well. RAD140 is known as one of the most potent SARMs out there, so you can take a small dosage and see a substantial effect on your body. Such SARMs are excellent alternatives for androgenic steroids because they come with all the benefits and none of the side effects. The RAD140 will help you cut fat and gain more muscle simultaneously, and it will do it very quickly. Short…
08Dec

S23: Dosage, Usage and Benefits

S23 is a non-steroidal Selective Androgen Receptor Modulator (SARM) from GTx Inc. SARMs are a new class of drugs that act like testosterone targeting certain receptors in the body located in muscle and bone tissues. Studies suggest these drugs can be effective for treating issues like muscle wasting and osteoporosis. However, the clinical research on these drugs is very lacking. S23 is a modified version of another SARM molecule known as C6. Just like other SARMs, the drug is not very well-studied. Still, there is a lot of promising data coming from animal studies. S23 is currently under investigation as a potential male contraceptive. According to the available studies, this SARM induced infertility in all the rats it was administered to. The effect was dose-dependent and temporary, meaning the mice regained their fertility immediately after the treatment was stopped. This makes S23 a potential oral male contraceptive. According to the…
08Dec

SR9011: Usage, Dosage & Benefits

What is SR9011? SR9011 is a Rev-ErbA agonist and is counted as one of the next big super drugs that might reign the pharmaceutical industry for a long time. SR9011 and the other agonists in the same series have maintained their research and observation status since 2012. Nearly eight years ago, the National Institute of Health issued grants and established funds for the project. Pharmacy research Professor Thomas Burris developed the research drug at St. Louis College of Pharmacy. The compound is still going through its intermediate stages of the trial. As of October 2020, the SR9011 is still not declared publicly available for human consumption. The lab and clinical trials have yet a lot to reveal. Benefits To fully understand the beneficial effects of agonist SR9011, it’s necessary to understand what the compound actually does. SR9011 is a Rev-ErbA agonist, which means it binds itself to the Rev-ErbA protein in our…

Posts navigation